NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in NextCure, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −2 vs. Q2 2023
- Shares held
- 12.9M
- −423.3K (−3.2%) vs. Q2 2023
- Total value
- $16.6M
- −$7.34M (−30.6%) vs. Q2 2023
- New holders
- 3
- 7 more added
- Sold out
- 5
- 14 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $2.78M |
| Q1 2026 | 26 | $23.0M |
| Q4 2025 | 24 | $26.9M |
| Q3 2025 | 17 | $5.03M |
| Q2 2025 | 30 | $5.65M |
| Q1 2025 | 38 | $7.38M |
| Q4 2024 | 46 | $13.1M |
| Q3 2024 | 44 | $21.7M |
| Q2 2024 | 49 | $25.5M |
| Q1 2024 | 47 | $36.0M |
| Q4 2023 | 43 | $15.3M |
| Q3 2023 | 41 | $16.6M |
| Q2 2023 | 43 | $24.0M |
| Q1 2023 | 44 | $19.6M |
| Q4 2022 | 45 | $18.9M |
| Q3 2022 | 52 | $41.8M |
| Q2 2022 | 51 | $67.9M |
| Q1 2022 | 59 | $64.3M |
| Q4 2021 | 71 | $86.2M |
| Q3 2021 | 71 | $99.5M |
| Q2 2021 | 78 | $124.2M |
| Q1 2021 | 92 | $179.8M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding NextCure, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1 | $1 | 0.00% | −300−99.7% | Reduced |
| Bank of America Corp | 2 | $2 | 0.00% | +2 | New |
| Qube Research & Technologies Ltd | 48 | $62 | 0.00% | +48 | New |
| Wells Fargo & Company | 146 | $188 | 0.00% | +16+12.3% | Added |
| BNP Paribas Arbitrage, SA | 385 | $497 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 703 | $906 | 0.00% | 00.0% | Unchanged |
| State of Wyoming | 2,613 | $3.37K | 0.00% | +2,613 | New |
| JPMorgan Chase & Co | 2,946 | $3.80K | 0.00% | +23+0.8% | Added |
| FMR LLC | 4,629 | $5.97K | 0.00% | −5,854−55.8% | Reduced |
| Tower Research Capital LLC (TRC) | 7,042 | $9.09K | 0.00% | +3,385+92.6% | Added |
| Charles Schwab Investment Management Inc | 10,000 | $12.9K | 0.00% | 00.0% | Unchanged |
| HarbourVest Partners LLC | 10,044 | $13.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 11,697 | $15.1K | 0.00% | −3,967−25.3% | Reduced |
| Susquehanna International Group, LLP | 13,094 | $16.9K | 0.00% | −26,187−66.7% | Reduced |
| HSBC Holdings PLC | 17,363 | $22.4K | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 19,588 | $25.3K | 0.00% | −5,072−20.6% | Reduced |
| ExodusPoint Capital Management, LP | 20,449 | $26.0K | 0.00% | −10,224−33.3% | Reduced |
| Ieq Capital, LLC | 37,342 | $48.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 43,014 | $55.5K | 0.00% | −460−1.1% | Reduced |
| State Street Corp | 57,092 | $73.6K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 58,200 | $75.1K | 0.00% | −16,000−21.6% | Reduced |
| Barclays PLC | 67,548 | $87.1K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 94,600 | $122.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 95,720 | $123.5K | 0.00% | −79,214−45.3% | Reduced |
| Sio Capital Management, LLC | 130,000 | $167.7K | 0.05% | 00.0% | Unchanged |
| Macquarie Group Ltd | 150,000 | $194.0K | 0.00% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 166,185 | $214.4K | 0.07% | −21,511−11.5% | Reduced |
| Geode Capital Management, LLC | 174,707 | $225.4K | 0.00% | +17,125+10.9% | Added |
| Renaissance Technologies LLC | 250,200 | $323.0K | 0.00% | +3,000+1.2% | Added |
| Acuitas Investments, LLC | 286,817 | $370.0K | 0.22% | −170.0% | Reduced |
| BML Capital Management, LLC | 306,465 | $395.3K | 0.36% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 366,826 | $473.2K | 0.00% | −1230.0% | Reduced |
| Tang Capital Management LLC | 400,000 | $516.0K | 0.07% | 00.0% | Unchanged |
| Citadel Advisors LLC | 438,610 | $565.8K | 0.00% | +45,347+11.5% | Added |
| Acadian Asset Management LLC | 488,440 | $628.0K | 0.00% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 556,105 | $717.4K | 0.10% | 00.0% | Unchanged |
| BlackRock Inc. | 898,106 | $1.16M | 0.00% | −27,214−2.9% | Reduced |
| Vanguard Group Inc | 903,427 | $1.17M | 0.00% | −5,046−0.6% | Reduced |
| Millennium Management LLC | 1,422,554 | $1.84M | 0.00% | +13,499+1.0% | Added |
| Sofinnova Investments, Inc. | 2,671,856 | $3.45M | 0.24% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,711,013 | $3.50M | 0.08% | 00.0% | Unchanged |
| Cardiff Park Advisors, LLC | 0 | $0 | 0.00% | −262,000−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −43,917−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −550−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −46−100.0% | Sold out |